MPM
DXCM icon

Meritage Portfolio Management’s DexCom DXCM Stock Holding History

Meritage Portfolio Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-57,204
Closed -$5.89M – 261
2020
Q3 		$5.89M Sell
57,204
-188
-0.3% -$19.6K 0.53% 52
2020
Q2 		$5.82M Buy
+57,392
New +$5.13M 0.56% 49

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Meritage Portfolio Management's DXCM Position: Q4 2020 in Review

Meritage Portfolio Management sold out of DexCom (DXCM) in Q4 2020, closing a stake of 57,204 shares — an estimated $5.89M sold.

Meritage Portfolio Management first reported a position in DXCM in Q2 2020 and held it in 2 quarters. The position peaked at $5.89M in Q3 2020. 732 funds tracked by Wall St. Rank hold DXCM as of Q4 2020.

  • Meritage Portfolio Management reported no remaining DexCom position as of Q4 2020 after selling out during the quarter.
  • Meritage Portfolio Management sold 57,204 DexCom shares in Q4 2020, an estimated $5.89M.
  • Meritage Portfolio Management first reported a position in DexCom in Q2 2020 and held it in 2 quarters.
  • Meritage Portfolio Management's DexCom position peaked at $5.89M in Q3 2020.
  • 732 funds tracked by Wall St. Rank held DexCom as of Q4 2020.

Based on Meritage Portfolio Management's 13F filing for Q4 2020, filed 3 Feb 2021.